At present, the treatment of liver cancer is still the preferred surgical resection. The survival rate of HCC is closely related to the foll
At present, the treatment of liver cancer is still the preferred surgical resection. The survival rate of HCC is closely related to the following factors.
(1) early resection: early resection is undoubtedly the key factor to improve the survival rate of disease-free survival. It has been reported that the survival rate of small hepatocellular carcinoma (HCC) is less than 79% cm, and the survival rate is less than 3 cm (less than 5 cm) by up to 83.3%. Therefore, early diagnosis and early treatment are closely related to the improvement of postoperative survival rate.
(2) intraoperative prevention: intraoperative preventive measures are essential to prolong disease-free survival. First, in the whole operation process to avoid the extrusion of liver and tumor, tumor increased pressure is an important cause of HCC metastasis; second, reduce the intraoperative blood loss and hepatic portal occlusion time; third, the inability to achieve a sufficient margin of liver wound should be treated accordingly, such as injection of anhydrous alcohol, anhydrous alcohol or chemotherapy the drug encapsulation, liver section microwave curing, freezing; fourth, visible should be tumor thrombus suction, intravascular perfusion chemotherapy; fifth, intraoperative ultrasonography contributes to radical resection; sixth, portal vein or hepatic artery with drug perfusion device (DDS) is a kind of desirable.
(3) postoperative comprehensive treatment: postoperative comprehensive treatment such as immunotherapy, DDS, chemotherapy and traditional Chinese medicine may also have different degrees of efficacy.
(4) reoperation for recurrence: reoperation is an important method for extending with tumor survival after resection of hepatocellular carcinoma, and 5 year survival rate more than the high number of up to 40%, other authors reported at home and abroad also confirmed the superiority of reoperation. Therefore, those who have recurrent liver cancer should actively promote the surgical resection or local ablation treatment.